TY - JOUR AU - Rawla, P. AU - Sunkara, T. AU - Gaduputi, V. PY - 2019 DA - 2019// TI - Epidemiology of pancreatic cancer: global trends, etiology and risk factors JO - World J Oncol VL - 10 UR - https://doi.org/10.14740/wjon1166 DO - 10.14740/wjon1166 ID - Rawla2019 ER - TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Kamisawa, T. AU - Wood, L. D. AU - Itoi, T. PY - 2016 DA - 2016// TI - Pancreatic cancer JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)00141-0 DO - 10.1016/S0140-6736(16)00141-0 ID - Kamisawa2016 ER - TY - JOUR AU - Du, T. AU - Bill, K. A. AU - Ford, J. PY - 2018 DA - 2018// TI - The diagnosis and staging of pancreatic cancer: A comparison of endoscopic ultrasound and computed tomography with pancreas protocol JO - Am J Surg VL - 215 UR - https://doi.org/10.1016/j.amjsurg.2017.11.021 DO - 10.1016/j.amjsurg.2017.11.021 ID - Du2018 ER - TY - STD TI - Singh RR, EMJD O’R. New treatment strategies for metastatic pancreatic ductal adenocarcinoma. Drugs. 2020;80:647–69. ID - ref5 ER - TY - JOUR AU - Uson Junior, P. L. S. AU - Rother, E. T. AU - Maluf, F. C. PY - 2018 DA - 2018// TI - Meta-analysis of modified folfirinox regimens for patients with metastatic pancreatic cancer JO - Clin Colorectal Cancer VL - 17 UR - https://doi.org/10.1016/j.clcc.2018.03.007 DO - 10.1016/j.clcc.2018.03.007 ID - Uson Junior2018 ER - TY - JOUR AU - Ottaiano, A. AU - Capozzi, M. AU - Divitiis, C. PY - 2017 DA - 2017// TI - Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: A meta-analysis of randomized phase iii trials JO - Acta Oncol VL - 56 UR - https://doi.org/10.1080/0284186X.2017.1288922 DO - 10.1080/0284186X.2017.1288922 ID - Ottaiano2017 ER - TY - JOUR AU - Kaur, H. AU - Bruno, J. G. AU - Kumar, A. PY - 2018 DA - 2018// TI - Aptamers in the therapeutics and diagnostics pipelines JO - Theranostics VL - 8 UR - https://doi.org/10.7150/thno.25958 DO - 10.7150/thno.25958 ID - Kaur2018 ER - TY - JOUR AU - Xiong, H. AU - Yan, J. AU - Cai, S. PY - 2019 DA - 2019// TI - Cancer protein biomarker discovery based on nucleic acid aptamers JO - Int J Biol Macromol VL - 132 UR - https://doi.org/10.1016/j.ijbiomac.2019.03.165 DO - 10.1016/j.ijbiomac.2019.03.165 ID - Xiong2019 ER - TY - STD TI - Nuzzo S, Roscigno G, Affinito A, et al. Potential and challenges of aptamers as specific carriers of therapeutic oligonucleotides for precision medicine in cancer. Cancers (Basel). 2019;11. ID - ref10 ER - TY - STD TI - Tuerk C, LJs G. Systematic evolution of ligands by exponential enrichment: Rna ligands to bacteriophage t4 DNA polymerase. Science. 1990;249:505–10. ID - ref11 ER - TY - STD TI - Komarova N, Kuznetsov A. Inside the black box: what makes selex better? Molecules. 2019;24. ID - ref12 ER - TY - STD TI - Gong S, Wang Y, Wang Z, et al. Computational methods for modeling aptamers and designing riboswitches. Int J Mol Sci. 2017;18. ID - ref13 ER - TY - JOUR AU - Maimaitiyiming, Y. AU - Hong, F. AU - Yang, C. PY - 2019 DA - 2019// TI - Novel insights into the role of aptamers in the fight against cancer JO - J Cancer Res Clin Oncol VL - 145 UR - https://doi.org/10.1007/s00432-019-02882-7 DO - 10.1007/s00432-019-02882-7 ID - Maimaitiyiming2019 ER - TY - JOUR AU - Munzar, J. D. AU - Ng, A. AU - Juncker, D. PY - 2019 DA - 2019// TI - Duplexed aptamers: history, design, theory, and application to biosensing JO - Chem Soc Rev VL - 48 UR - https://doi.org/10.1039/C8CS00880A DO - 10.1039/C8CS00880A ID - Munzar2019 ER - TY - JOUR AU - Ghorbani, F. AU - Abbaszadeh, H. AU - Dolatabadi, J. E. N. PY - 2019 DA - 2019// TI - Application of various optical and electrochemical aptasensors for detection of human prostate specific antigen: A review JO - Biosens Bioelectron VL - 142 UR - https://doi.org/10.1016/j.bios.2019.111484 DO - 10.1016/j.bios.2019.111484 ID - Ghorbani2019 ER - TY - JOUR AU - Yousefi, M. AU - Dehghani, S. AU - Nosrati, R. PY - 2019 DA - 2019// TI - Aptasensors as a new sensing technology developed for the detection of muc1 mucin: A review JO - Biosens Bioelectron VL - 130 UR - https://doi.org/10.1016/j.bios.2019.01.015 DO - 10.1016/j.bios.2019.01.015 ID - Yousefi2019 ER - TY - JOUR AU - Gu, L. AU - Yan, W. AU - Liu, S. PY - 2018 DA - 2018// TI - Trypsin enhances aptamer screening: A novel method for targeting proteins JO - Anal Biochem VL - 561–562 UR - https://doi.org/10.1016/j.ab.2018.09.004 DO - 10.1016/j.ab.2018.09.004 ID - Gu2018 ER - TY - JOUR AU - Meng, Q. AU - Shi, S. AU - Liang, C. PY - 2017 DA - 2017// TI - Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: A systematic review and meta-analysis JO - Onco Targets Ther VL - 10 UR - https://doi.org/10.2147/OTT.S145708 DO - 10.2147/OTT.S145708 ID - Meng2017 ER - TY - JOUR AU - Khanmohammadi, A. AU - Aghaie, A. AU - Vahedi, E. PY - 2020 DA - 2020// TI - Electrochemical biosensors for the detection of lung cancer biomarkers: A review JO - Talanta VL - 206 UR - https://doi.org/10.1016/j.talanta.2019.120251 DO - 10.1016/j.talanta.2019.120251 ID - Khanmohammadi2020 ER - TY - JOUR AU - Xiang, W. AU - Lv, Q. AU - Shi, H. PY - 2020 DA - 2020// TI - Aptamer-based biosensor for detecting carcinoembryonic antigen JO - Talanta VL - 214 UR - https://doi.org/10.1016/j.talanta.2020.120716 DO - 10.1016/j.talanta.2020.120716 ID - Xiang2020 ER - TY - STD TI - Tang Z, ZJMA M. Ultrasensitive amperometric immunoassay for carcinoembryonic antigens by using a glassy carbon electrode coated with a polydopamine-pb (ii) redox system and a chitosan-gold nanocomposite. Microchim Acta. 2017;184:1135–42. ID - ref22 ER - TY - JOUR AU - Huang, J. Y. AU - Zhao, L. AU - Lei, W. PY - 2018 DA - 2018// TI - A high-sensitivity electrochemical aptasensor of carcinoembryonic antigen based on graphene quantum dots-ionic liquid-nafion nanomatrix and dnazyme-assisted signal amplification strategy JO - Biosens Bioelectron VL - 99 UR - https://doi.org/10.1016/j.bios.2017.07.036 DO - 10.1016/j.bios.2017.07.036 ID - Huang2018 ER - TY - STD TI - Vainer N, Dehlendorff C, JSJO J. Systematic literature review of il-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer. Oncotarget. 2018;9:29820. ID - ref24 ER - TY - JOUR AU - Hao, Z. AU - Pan, Y. AU - Huang, C. PY - 2019 DA - 2019// TI - Sensitive detection of lung cancer biomarkers using an aptameric graphene-based nanosensor with enhanced stability JO - Biomed Microdevices VL - 21 UR - https://doi.org/10.1007/s10544-019-0409-6 DO - 10.1007/s10544-019-0409-6 ID - Hao2019 ER - TY - STD TI - Tertiş M, Ciui B, Suciu M, et al. Label-free electrochemical aptasensor based on gold and polypyrrole nanoparticles for interleukin 6 detection. Electrochim Acta. 2017;258:1208–18. ID - ref26 ER - TY - STD TI - Mroczko B, Lukaszewicz-Zajac M, Wereszczynska-Siemiatkowska U, et al. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: Metalloproteinase-9 as an independent prognostic factor. Pancreas. 2009;38:613–8. ID - ref27 ER - TY - JOUR AU - Mondal, S. AU - Adhikari, N. AU - Banerjee, S. PY - 2020 DA - 2020// TI - Matrix metalloproteinase-9 (mmp-9) and its inhibitors in cancer: A minireview JO - Eur J Med Chem VL - 194 UR - https://doi.org/10.1016/j.ejmech.2020.112260 DO - 10.1016/j.ejmech.2020.112260 ID - Mondal2020 ER - TY - JOUR AU - Scarano, S. AU - Dausse, E. AU - Crispo, F. PY - 2015 DA - 2015// TI - Design of a dual aptamer-based recognition strategy for human matrix metalloproteinase 9 protein by piezoelectric biosensors JO - Anal Chim Acta VL - 897 UR - https://doi.org/10.1016/j.aca.2015.07.009 DO - 10.1016/j.aca.2015.07.009 ID - Scarano2015 ER - TY - JOUR AU - Kunovsky, L. AU - Tesarikova, P. AU - Kala, Z. PY - 2018 DA - 2018// TI - The use of biomarkers in early diagnostics of pancreatic cancer JO - Can J Gastroenterol Hepatol VL - 2018 UR - https://doi.org/10.1155/2018/5389820 DO - 10.1155/2018/5389820 ID - Kunovsky2018 ER - TY - STD TI - Ferrara N, Gerber H-P, JJNm LC. The biology of vegf and its receptors. Nat Med. 2003;9:669–76. ID - ref31 ER - TY - JOUR AU - Dehghani, S. AU - Nosrati, R. AU - Yousefi, M. PY - 2018 DA - 2018// TI - Aptamer-based biosensors and nanosensors for the detection of vascular endothelial growth factor (vegf): A review JO - Biosens Bioelectron VL - 110 UR - https://doi.org/10.1016/j.bios.2018.03.037 DO - 10.1016/j.bios.2018.03.037 ID - Dehghani2018 ER - TY - STD TI - Khosravi F, Loeian SM, Panchapakesan B. Ultrasensitive label-free sensing of il-6 based on pase functionalized carbon nanotube micro-arrays with rna-aptamers as molecular recognition elements. Biosensors (Basel). 2017;7. ID - ref33 ER - TY - JOUR AU - Freeman, R. AU - Girsh, J. AU - Jou, A. F. PY - 2012 DA - 2012// TI - Optical aptasensors for the analysis of the vascular endothelial growth factor (vegf) JO - Anal Chem VL - 84 UR - https://doi.org/10.1021/ac3011473 DO - 10.1021/ac3011473 ID - Freeman2012 ER - TY - STD TI - Zhao S, Yang W, RYJB L, et al. A folding-based electrochemical aptasensor for detection of vascular endothelial growth factor in human whole blood. Biosens Bioelectron. 2011;26:2442–7. ID - ref35 ER - TY - STD TI - Sundling KE, ACJAiap L. Circulating tumor cells: Overview and opportunities in cytology. Adv Anat Pathol. 2019;26:56–63. ID - ref36 ER - TY - JOUR AU - Safarpour, H. AU - Dehghani, S. AU - Nosrati, R. PY - 2020 DA - 2020// TI - Optical and electrochemical-based nano-aptasensing approaches for the detection of circulating tumor cells (ctcs) JO - Biosens Bioelectron VL - 148 UR - https://doi.org/10.1016/j.bios.2019.111833 DO - 10.1016/j.bios.2019.111833 ID - Safarpour2020 ER - TY - JOUR AU - Dua, P. AU - Kang, H. S. AU - Hong, S. M. PY - 2013 DA - 2013// TI - Alkaline phosphatase alppl-2 is a novel pancreatic carcinoma-associated protein JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-3682 DO - 10.1158/0008-5472.CAN-12-3682 ID - Dua2013 ER - TY - JOUR AU - Shin, H. S. AU - Jung, S. B. AU - Park, S. PY - 2019 DA - 2019// TI - Alppl2 is a potential diagnostic biomarker for pancreatic cancer-derived extracellular vesicles JO - Mol Ther Methods Clin Dev VL - 15 UR - https://doi.org/10.1016/j.omtm.2019.08.016 DO - 10.1016/j.omtm.2019.08.016 ID - Shin2019 ER - TY - JOUR AU - Wu, X. AU - Zhao, Z. AU - Bai, H. PY - 2015 DA - 2015// TI - DNA aptamer selected against pancreatic ductal adenocarcinoma for in vivo imaging and clinical tissue recognition JO - Theranostics VL - 5 UR - https://doi.org/10.7150/thno.11938 DO - 10.7150/thno.11938 ID - Wu2015 ER - TY - JOUR AU - Champanhac, C. AU - Teng, I. T. AU - Cansiz, S. PY - 2015 DA - 2015// TI - Development of a panel of DNA aptamers with high affinity for pancreatic ductal adenocarcinoma JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep16788 DO - 10.1038/srep16788 ID - Champanhac2015 ER - TY - STD TI - Kim YJ, Lee HS, Jung DE, et al. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer. J Mol Recognit. 2017;30. ID - ref42 ER - TY - STD TI - Mitra A, Mishra L, Li SJO. Emt, ctcs and cscs in tumor relapse and drug-resistance. Oncotarget. 2015;6:10697. ID - ref43 ER - TY - STD TI - Ray P, Sullenger BA, White RR. Further characterization of the target of a potential aptamer biomarker for pancreatic cancer: Cyclophilin b and its posttranslational modifications. Nucleic Acid Ther. 2013;23:435–42. ID - ref44 ER - TY - JOUR AU - Ray, P. AU - Rialon-Guevara, K. L. AU - Veras, E. PY - 2012 DA - 2012// TI - Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin b as a candidate pancreatic cancer biomarker JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI62385 DO - 10.1172/JCI62385 ID - Ray2012 ER - TY - JOUR AU - Zhang, J. AU - Li, S. AU - Liu, F. PY - 2015 DA - 2015// TI - Selex aptamer used as a probe to detect circulating tumor cells in peripheral blood of pancreatic cancer patients JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0121920 DO - 10.1371/journal.pone.0121920 ID - Zhang2015 ER - TY - JOUR AU - Tummers, W. S. AU - Willmann, J. K. AU - Bonsing, B. A. PY - 2018 DA - 2018// TI - Advances in diagnostic and intraoperative molecular imaging of pancreatic cancer JO - Pancreas VL - 47 UR - https://doi.org/10.1097/MPA.0000000000001075 DO - 10.1097/MPA.0000000000001075 ID - Tummers2018 ER - TY - JOUR AU - Amouzadeh Tabrizi, M. AU - Shamsipur, M. AU - Farzin, L. PY - 2015 DA - 2015// TI - A high sensitive electrochemical aptasensor for the determination of vegf(165) in serum of lung cancer patient JO - Biosens Bioelectron VL - 74 UR - https://doi.org/10.1016/j.bios.2015.07.032 DO - 10.1016/j.bios.2015.07.032 ID - Amouzadeh Tabrizi2015 ER - TY - JOUR AU - Wang, C. Y. AU - Lin, B. L. AU - Chen, C. H. PY - 2016 DA - 2016// TI - An aptamer targeting shared tumor-specific peptide antigen of mage-a3 in multiple cancers JO - Int J Cancer VL - 138 UR - https://doi.org/10.1002/ijc.29826 DO - 10.1002/ijc.29826 ID - Wang2016 ER - TY - JOUR AU - Kim, Y. H. AU - Sung, H. J. AU - Kim, S. PY - 2011 DA - 2011// TI - An rna aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells JO - Cancer Lett VL - 313 UR - https://doi.org/10.1016/j.canlet.2011.08.027 DO - 10.1016/j.canlet.2011.08.027 ID - Kim2011 ER - TY - JOUR AU - Huang, X. AU - Zhong, J. AU - Ren, J. PY - 2019 DA - 2019// TI - A DNA aptamer recognizing mmp14 for in vivo and in vitro imaging identified by cell-selex JO - Oncol Lett VL - 18 ID - Huang2019 ER - TY - JOUR AU - Wang, H. AU - Lam, C. H. AU - Li, X. PY - 2018 DA - 2018// TI - Selection of pd1/pd-l1 x-aptamers JO - Biochimie VL - 145 UR - https://doi.org/10.1016/j.biochi.2017.09.006 DO - 10.1016/j.biochi.2017.09.006 ID - Wang2018 ER - TY - JOUR AU - Yoon, S. AU - Armstrong, B. AU - Habib, N. PY - 2017 DA - 2017// TI - Blind selex approach identifies rna aptamers that regulate emt and inhibit metastasis JO - Mol Cancer Res VL - 15 UR - https://doi.org/10.1158/1541-7786.MCR-16-0462 DO - 10.1158/1541-7786.MCR-16-0462 ID - Yoon2017 ER - TY - JOUR AU - Yoon, S. AU - Huang, K. W. AU - Andrikakou, P. PY - 2019 DA - 2019// TI - Targeted delivery of c/ebpalpha-sarna by rna aptamers shows anti-tumor effects in a mouse model of advanced pdac JO - Mol Ther Nucleic Acids VL - 18 UR - https://doi.org/10.1016/j.omtn.2019.08.017 DO - 10.1016/j.omtn.2019.08.017 ID - Yoon2019 ER - TY - JOUR AU - Yoon, S. AU - Huang, K. W. AU - Reebye, V. PY - 2016 DA - 2016// TI - Targeted delivery of c/ebpalpha -sarna by pancreatic ductal adenocarcinoma-specific rna aptamers inhibits tumor growth in vivo JO - Mol Ther VL - 24 UR - https://doi.org/10.1038/mt.2016.60 DO - 10.1038/mt.2016.60 ID - Yoon2016 ER - TY - JOUR AU - Ray, P. AU - Cheek, M. A. AU - Sharaf, M. L. PY - 2012 DA - 2012// TI - Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells JO - Nucleic Acid Ther VL - 22 UR - https://doi.org/10.1089/nat.2012.0353 DO - 10.1089/nat.2012.0353 ID - Ray2012 ER - TY - STD TI - Yazdian-Robati R, Bayat P, Oroojalian F, et al. Therapeutic applications of as1411 aptamer, an update review. Int J Biol Macromol. 2019;155:1420-31. ID - ref57 ER - TY - JOUR AU - Porciani, D. AU - Tedeschi, L. AU - Marchetti, L. PY - 2015 DA - 2015// TI - Aptamer-mediated codelivery of doxorubicin and nf-kappab decoy enhances chemosensitivity of pancreatic tumor cells JO - Mol Ther Nucleic Acids VL - 4 UR - https://doi.org/10.1038/mtna.2015.9 DO - 10.1038/mtna.2015.9 ID - Porciani2015 ER - TY - STD TI - Catuogno S, Esposito CL. Aptamer cell-based selection: overview and advances. Biomedicines. 2017;5. ID - ref59 ER - TY - JOUR AU - Vokes, E. E. PY - 1997 DA - 1997// TI - Combined modality therapy of solid tumours JO - Lancet VL - 349 UR - https://doi.org/10.1016/S0140-6736(97)90011-8 DO - 10.1016/S0140-6736(97)90011-8 ID - Vokes1997 ER - TY - JOUR AU - Dam, D. H. AU - Lee, R. C. AU - Odom, T. W. PY - 2014 DA - 2014// TI - Improved in vitro efficacy of gold nanoconstructs by increased loading of g-quadruplex aptamer JO - Nano Lett VL - 14 UR - https://doi.org/10.1021/nl500844m DO - 10.1021/nl500844m ID - Dam2014 ER - TY - JOUR AU - Ludwig, H. AU - Weisel, K. AU - Petrucci, M. T. PY - 2017 DA - 2017// TI - Olaptesed pegol, an anti-cxcl12/sdf-1 spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: A phase iia study JO - Leukemia VL - 31 UR - https://doi.org/10.1038/leu.2017.5 DO - 10.1038/leu.2017.5 ID - Ludwig2017 ER - TY - JOUR AU - Park, J. Y. AU - Cho, Y. L. AU - Chae, J. R. PY - 2018 DA - 2018// TI - Gemcitabine-incorporated g-quadruplex aptamer for targeted drug delivery into pancreas cancer JO - Mol Ther Nucleic Acids VL - 12 UR - https://doi.org/10.1016/j.omtn.2018.06.003 DO - 10.1016/j.omtn.2018.06.003 ID - Park2018 ER - TY - JOUR AU - Lale, S. V. AU - GA, R. AU - Aravind, A. PY - 2014 DA - 2014// TI - As1411 aptamer and folic acid functionalized ph-responsive atrp fabricated ppegma-pcl-ppegma polymeric nanoparticles for targeted drug delivery in cancer therapy JO - Biomacromolecules VL - 15 UR - https://doi.org/10.1021/bm5001263 DO - 10.1021/bm5001263 ID - Lale2014 ER - TY - JOUR AU - Dua, P. AU - Kim, S. PY - 2015 DA - 2015// TI - Alppl2 aptamer-mediated targeted delivery of 5-fluoro-2′-deoxyuridine to pancreatic cancer JO - Nucleic Acid Ther VL - 25 UR - https://doi.org/10.1089/nat.2014.0516 DO - 10.1089/nat.2014.0516 ID - Dua2015 ER - TY - JOUR AU - Yoon, S. AU - Huang, K. W. AU - Reebye, V. PY - 2017 DA - 2017// TI - Aptamer-drug conjugates of active metabolites of nucleoside analogs and cytotoxic agents inhibit pancreatic tumor cell growth JO - Mol Ther Nucleic Acids VL - 6 UR - https://doi.org/10.1016/j.omtn.2016.11.008 DO - 10.1016/j.omtn.2016.11.008 ID - Yoon2017 ER - TY - STD TI - Halama N, Prüfer U, Froemming A, et al. Phase i/ii study with cxcl12 inhibitor nox-a12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer. Ann Oncol. 2019;30. ID - ref67 ER - TY - JOUR AU - Wu, J. AU - Wang, C. AU - Li, X. PY - 2012 DA - 2012// TI - Identification, characterization and application of a g-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2 JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0046393 DO - 10.1371/journal.pone.0046393 ID - Wu2012 ER - TY - STD TI - Wang C, Liu B, Xu X, et al. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine. Oncotarget. 2016;7:8360. ID - ref69 ER - TY - JOUR AU - Kratschmer, C. AU - Levy, M. PY - 2018 DA - 2018// TI - Targeted delivery of auristatin-modified toxins to pancreatic cancer using aptamers JO - Mol Ther Nucleic Acids VL - 10 UR - https://doi.org/10.1016/j.omtn.2017.11.013 DO - 10.1016/j.omtn.2017.11.013 ID - Kratschmer2018 ER - TY - JOUR AU - Hennequin, C. AU - Guillerm, S. AU - Quero, L. PY - 2019 DA - 2019// TI - Combination of chemotherapy and radiotherapy: A thirty years evolution JO - Cancer Radiother VL - 23 UR - https://doi.org/10.1016/j.canrad.2019.07.157 DO - 10.1016/j.canrad.2019.07.157 ID - Hennequin2019 ER - TY - JOUR AU - Orth, M. AU - Metzger, P. AU - Gerum, S. PY - 2019 DA - 2019// TI - Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches JO - Radiat Oncol VL - 14 UR - https://doi.org/10.1186/s13014-019-1345-6 DO - 10.1186/s13014-019-1345-6 ID - Orth2019 ER - TY - JOUR AU - Zhang, X. AU - Peng, L. AU - Liang, Z. PY - 2018 DA - 2018// TI - Effects of aptamer to u87-egfrviii cells on the proliferation, radiosensitivity, and radiotherapy of glioblastoma cells JO - Mol Ther Nucleic Acids VL - 10 UR - https://doi.org/10.1016/j.omtn.2018.01.001 DO - 10.1016/j.omtn.2018.01.001 ID - Zhang2018 ER - TY - JOUR AU - Liu, Y. AU - Zhang, P. AU - Li, F. PY - 2018 DA - 2018// TI - Metal-based nanoenhancers for future radiotherapy: Radiosensitizing and synergistic effects on tumor cells JO - Theranostics VL - 8 UR - https://doi.org/10.7150/thno.22172 DO - 10.7150/thno.22172 ID - Liu2018 ER - TY - STD TI - Ghahremani F, Kefayat A, Shahbazi-Gahrouei D, et al. As1411 aptamer-targeted gold nanoclusters effect on the enhancement of radiation therapy efficacy in breast tumor-bearing mice. Nanomedicine. 2018;13:2563–78. ID - ref75 ER - TY - JOUR AU - Zhao, J. AU - Liu, P. AU - Ma, J. PY - 2019 DA - 2019// TI - Enhancement of radiosensitization by silver nanoparticles functionalized with polyethylene glycol and aptamer as1411 for glioma irradiation therapy JO - Int J Nanomedicine VL - 14 UR - https://doi.org/10.2147/IJN.S224160 DO - 10.2147/IJN.S224160 ID - Zhao2019 ER - TY - JOUR AU - Alves, L. N. AU - Missailidis, S. AU - Lage, C. A. S. PY - 2019 DA - 2019// TI - Anti-muc1 aptamer as carrier tool of the potential radiosensitizer 1,10 phenanthroline in mcf-7 breast cancer cells JO - Anticancer Res VL - 39 UR - https://doi.org/10.21873/anticanres.13293 DO - 10.21873/anticanres.13293 ID - Alves2019 ER - TY - JOUR AU - Burdick, M. D. AU - Harris, A. AU - Reid, C. J. PY - 1997 DA - 1997// TI - Oligosaccharides expressed on muc1 produced by pancreatic and colon tumor cell lines JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.39.24198 DO - 10.1074/jbc.272.39.24198 ID - Burdick1997 ER - TY - JOUR AU - Ni, X. AU - Zhang, Y. AU - Ribas, J. PY - 2011 DA - 2011// TI - Prostate-targeted radiosensitization via aptamer-shrna chimeras in human tumor xenografts JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI45109 DO - 10.1172/JCI45109 ID - Ni2011 ER - TY - JOUR AU - Ni, X. AU - Zhang, Y. AU - Zennami, K. PY - 2015 DA - 2015// TI - Systemic administration and targeted radiosensitization via chemically synthetic aptamer-sirna chimeras in human tumor xenografts JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-15-0291-T DO - 10.1158/1535-7163.MCT-15-0291-T ID - Ni2015 ER - TY - JOUR AU - Ren, H. AU - Zhang, H. AU - Wang, X. PY - 2014 DA - 2014// TI - Prostate-specific membrane antigen as a marker of pancreatic cancer cells JO - Med Oncol VL - 31 UR - https://doi.org/10.1007/s12032-014-0857-z DO - 10.1007/s12032-014-0857-z ID - Ren2014 ER - TY - JOUR AU - Zhang, S. AU - Gupta, S. AU - Fitzgerald, T. J. PY - 2018 DA - 2018// TI - Dual radiosensitization and anti-stat3 anti-proliferative strategy based on delivery of gold nanoparticle - oligonucleotide nanoconstructs to head and neck cancer cells JO - Nanotheranostics VL - 2 UR - https://doi.org/10.7150/ntno.22335 DO - 10.7150/ntno.22335 ID - Zhang2018 ER - TY - JOUR AU - Almeida, C. E. B. AU - Alves, L. N. AU - Rocha, H. F. PY - 2017 DA - 2017// TI - Aptamer delivery of sirna, radiopharmaceutics and chemotherapy agents in cancer JO - Int J Pharm VL - 525 UR - https://doi.org/10.1016/j.ijpharm.2017.03.086 DO - 10.1016/j.ijpharm.2017.03.086 ID - Almeida2017 ER - TY - JOUR AU - Bandekar, A. AU - Zhu, C. AU - Jindal, R. PY - 2014 DA - 2014// TI - Anti-prostate-specific membrane antigen liposomes loaded with 225ac for potential targeted antivascular alpha-particle therapy of cancer JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.125476 DO - 10.2967/jnumed.113.125476 ID - Bandekar2014 ER - TY - JOUR AU - Schrand, B. AU - Verma, B. AU - Levay, A. PY - 2017 DA - 2017// TI - Radiation-induced enhancement of antitumor t-cell immunity by vegf-targeted 4-1bb costimulation JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-2105 DO - 10.1158/0008-5472.CAN-16-2105 ID - Schrand2017 ER - TY - JOUR AU - Benaduce, A. P. AU - Brenneman, R. AU - Schrand, B. PY - 2016 DA - 2016// TI - 4-1bb aptamer-based immunomodulation enhances the therapeutic index of radiation therapy in murine tumor models JO - Int J Radiat Oncol Biol Phys VL - 96 UR - https://doi.org/10.1016/j.ijrobp.2016.05.013 DO - 10.1016/j.ijrobp.2016.05.013 ID - Benaduce2016 ER - TY - STD TI - Lakhin A, Tarantul V, LJAN G. Aptamers: Problems, solutions and prospects. Acta Naturae. 2013;5:34-43. ID - ref87 ER - TY - STD TI - Ni S, Yao H, Wang L, et al. Chemical modifications of nucleic acid aptamers for therapeutic purposes. Int J Mol Sci. 2017;18. ID - ref88 ER - TY - STD TI - Chandola C, Neerathilingam M. Aptamers for targeted delivery: current challenges and future opportunities role of novel drug delivery vehicles in nanobiomedicine: IntechOpen; 2019;126:67-75. ID - ref89 ER - TY - JOUR AU - Guo, C. AU - Su, F. AU - Song, Y. PY - 2017 DA - 2017// TI - Aptamer-templated silver nanoclusters embedded in zirconium metal-organic framework for bifunctional electrochemical and spr aptasensors toward carcinoembryonic antigen JO - ACS Appl Mater Interfaces VL - 9 UR - https://doi.org/10.1021/acsami.7b14952 DO - 10.1021/acsami.7b14952 ID - Guo2017 ER - TY - JOUR AU - Wang, D. AU - Li, Y. AU - Lin, Z. PY - 2015 DA - 2015// TI - Surface-enhanced electrochemiluminescence of ru@sio2 for ultrasensitive detection of carcinoembryonic antigen JO - Anal Chem VL - 87 UR - https://doi.org/10.1021/acs.analchem.5b01038 DO - 10.1021/acs.analchem.5b01038 ID - Wang2015 ER - TY - JOUR AU - Shi, G. F. AU - Cao, J. T. AU - Zhang, J. J. PY - 2014 DA - 2014// TI - Aptasensor based on tripetalous cadmium sulfide-graphene electrochemiluminescence for the detection of carcinoembryonic antigen JO - Analyst VL - 139 UR - https://doi.org/10.1039/C4AN01311E DO - 10.1039/C4AN01311E ID - Shi2014 ER - TY - JOUR AU - Wu, X. AU - Liu, H. AU - Han, D. PY - 2019 DA - 2019// TI - Elucidation and structural modeling of cd71 as a molecular target for cell-specific aptamer binding JO - J Am Chem Soc VL - 141 UR - https://doi.org/10.1021/jacs.9b03720 DO - 10.1021/jacs.9b03720 ID - Wu2019 ER - TY - JOUR AU - Clawson, G. A. AU - Abraham, T. AU - Pan, W. PY - 2017 DA - 2017// TI - A cholecystokinin b receptor-specific DNA aptamer for targeting pancreatic ductal adenocarcinoma JO - Nucleic Acid Ther VL - 27 UR - https://doi.org/10.1089/nat.2016.0621 DO - 10.1089/nat.2016.0621 ID - Clawson2017 ER - TY - JOUR AU - He, X. AU - Chen, X. AU - Liu, L. PY - 2018 DA - 2018// TI - Sequentially triggered nanoparticles with tumor penetration and intelligent drug release for pancreatic cancer therapy JO - Adv Sci (Weinh) VL - 5 UR - https://doi.org/10.1002/advs.201701070 DO - 10.1002/advs.201701070 ID - He2018 ER -